2013 Dodge Avenger SE V6
3.6 L • 6 • FWD • AT
1C3CDZAG3DN541154
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.6 L • 6 • FWD • AT
Odometer
81,907 mi ≈ 131,816 km
Primary damage
Front end
Docs
IL • Salvage
Auction
VIN
1C3CDZAG3DN541154
Lot number
67908215
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Southern Illinois, IL
Description
Fuel type
Gasoline
Body color
Blue
Body type
Sedan
Generation
JS
Trim
SE V6
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Dodge models
2013 Dodge Avenger SE V6 • 3.6 L • 6 cyl • FWD • Automatic • Copart Lot: 67908215 • VIN: 1C3CDZAG3DN541154
Find out more about this 2013 Dodge Avenger SE V6, available at the Copart salvage car auction as lot #67908215 in Southern Illinois, IL. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 81,907 mi. This Blue Dodge Avenger Sedan is equipped with Gasoline 3.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1C3CDZAG3DN541154 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
